BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 80 found
  Current Search:  rheumatic: 80     

HTML
100%
Systemic chemotherapy for bladder cancer
Print Save in My Library Free Abstract Retz M et al.

- This review summarizes the results of first-line and second-line systemic chemotherapy for advanced urothelial carcinoma as well as data from adjuvant and neoadjuvant trials for...

MDLinx:  Jul 2 2009 7:49PM
Matching: rheumatic
Find similar documents
HTML
100%
Improving the physician-patient cardiovascular risk dialogue to improve statin adherence
Save in My Library Free Full Text Casebeer L et al.

- Patients new to statin therapy exposed to a patient counseling and education program achieved a 12.4 higher average number of statin prescription fill days and were 10% more likely to...

MDLinx:  Jul 1 2009 5:01PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Rehab Manegement:  Jun 30 2009 3:59AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI„ (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rh
3680 live jobs on PharmiWeb.com now Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect Autoinjector Horsham, PA and Kenilworth, NJ (June 25, 2009) Centocor Ortho Biotech Inc.
PharmiWeb:  Jun 29 2009 7:02PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect Autoinjector Horsham, PA and Kenilworth, NJ.

- Centocor Ortho Biotech Inc.

and Schering-Plough Corporation (NYSE: SGP)...

WebWire:  Jun 29 2009 3:54PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Financials.com:  Jun 28 2009 4:50PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 (HSMN NewsFeed) -- Centocor Ortho Biotech Inc.

and Schering...

Healthcare Sales & Marketing Network:  Jun 27 2009 9:16AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

RT Magazine:  Jun 26 2009 8:56PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

KSLA:  Jun 26 2009 8:54PM
Matching: rheumatic
Find similar documents
HTML
100%
EU Agency Backs New Centocor Ortho Biotech Inc., Schering-Plough Corporation (SGP) (JOBS) Arthritis Drug
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- and Schering-Plough Corporation...

BioSpace:  Jun 26 2009 5:44PM
Matching: rheumatic
Find similar documents
HTML
100%
Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver
Arthralgia 5350%, myalgia 5861% and fatigue 6481% were detected in HBV and HCV groups in order All manifestations did not differ between groups Pain intensity was higher in HCV group Artralgia was associated with viral load of the pts in...
MDLinx:  Jun 26 2009 5:31PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Montana's News Station:  Jun 26 2009 5:20PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

KOTA Territory News:  Jun 26 2009 4:18PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Pharmacy Choice:  Jun 26 2009 3:36PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

KLFY:  Jun 26 2009 1:09PM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Dayton Business Journal:  Jun 26 2009 11:45AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Austin Business Journal:  Jun 26 2009 11:38AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Nashville Business Journal:  Jun 26 2009 11:28AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Atlanta Business Chronicle:  Jun 26 2009 11:04AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

South Florida Business Journal:  Jun 26 2009 10:53AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Memphis Business Journal:  Jun 26 2009 10:50AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

Upon Commission approval in the European Union, SIMPONI given as a 50 mg subcutaneous...

Forbes.com:  Jun 26 2009 10:45AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Columbus Business First:  Jun 26 2009 10:32AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

San Jose Business Journal:  Jun 26 2009 10:31AM
Matching: rheumatic
Find similar documents
HTML
100%
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumat
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa.

and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.

and...

Kansas City Business Journal:  Jun 26 2009 10:28AM
Matching: rheumatic
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.